Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

IMRT all the way.

Klopp AH, Eifel PJ.

Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):692-693. doi: 10.1016/j.ijrobp.2019.07.051. No abstract available.

PMID:
31655653
2.

Pelvic Insufficiency Fractures After External Beam Radiation Therapy for Gynecologic Cancers: A Meta-analysis and Meta-regression of 3929 Patients.

Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G.

Int J Radiat Oncol Biol Phys. 2019 Sep 30. pii: S0360-3016(19)33836-2. doi: 10.1016/j.ijrobp.2019.09.012. [Epub ahead of print]

PMID:
31580930
3.

Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.

Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, Jazaeri A, Jhingran A, Schmeler KM, Daniel CR, Klopp A.

Gynecol Oncol. 2019 Nov;155(2):237-244. doi: 10.1016/j.ygyno.2019.09.002. Epub 2019 Sep 26.

PMID:
31500892
4.

MRI for Radiation Therapy Planning in Human Papillomavirus-associated Gynecologic Cancers.

Venkatesan AM, Menias CO, Jones KM, Rauch GM, Stafford RJ, Klopp AH.

Radiographics. 2019 Sep-Oct;39(5):1476-1500. doi: 10.1148/rg.2019180121.

PMID:
31498740
5.

Scores and Misses With New Technology-Walking the Narrow Path of Evidence.

Beriwal S, Lee LJ, Chino JP, Albuquerque K, Klopp AH.

Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):237-241. doi: 10.1016/j.ijrobp.2019.05.015. Review. No abstract available.

PMID:
31492378
6.

An evaluation of gender diversity in the American Brachytherapy Society.

Lu DJ, Luu M, Yashar CM, Klopp AH, Kamrava M.

Brachytherapy. 2019 Nov - Dec;18(6):835-840. doi: 10.1016/j.brachy.2019.07.003. Epub 2019 Aug 8.

PMID:
31402211
7.

Dual-Energy X-Ray Absorptiometry Compared to Computed Tomography for Visceral Adiposity Assessment Among Gastrointestinal and Pancreatic Cancer Survivors.

Coletta AM, Klopp AH, Fogelman D, Parikh AM, Li Y, Garg N, Basen-Engquist K.

Sci Rep. 2019 Aug 8;9(1):11500. doi: 10.1038/s41598-019-48027-1.

8.

Experience in commissioning the halcyon linac.

Netherton T, Li Y, Gao S, Klopp A, Balter P, Court LE, Scheuermann R, Kennedy C, Dong L, Metz J, Mihailidis D, Ling C, Young Lee M, Constantin M, Thompson S, Kauppinen J, Uusitalo P.

Med Phys. 2019 Oct;46(10):4304-4313. doi: 10.1002/mp.13723. Epub 2019 Aug 27.

PMID:
31310678
9.

Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis.

Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G.

Brachytherapy. 2019 Sep - Oct;18(5):620-626. doi: 10.1016/j.brachy.2019.04.272. Epub 2019 May 31.

PMID:
31160198
10.

Development and Implementation of a Simulation-Based Educational Workshop on Gynecological Brachytherapy: Pilot Study at a National Meeting.

Singer L, Braunstein S, Klopp A, Joyner M.

Pract Radiat Oncol. 2019 Sep - Oct;9(5):e465-e472. doi: 10.1016/j.prro.2019.05.006. Epub 2019 May 22.

PMID:
31128303
11.

Patterns of treatment failure in patients undergoing adjuvant or definitive radiotherapy for vulvar cancer.

Vorbeck CS, Jhingran A, Iyer RB, Loft A, Klopp A, Mirza MR, Sobremonte A, Vedam S, Vogelius IR.

Int J Gynecol Cancer. 2019 May 23. pii: ijgc-2019-000223. doi: 10.1136/ijgc-2019-000223. [Epub ahead of print]

PMID:
31126968
12.

Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.

Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH.

Gynecol Oncol. 2019 Jul;154(1):22-28. doi: 10.1016/j.ygyno.2019.05.002. Epub 2019 May 17.

PMID:
31109659
13.

Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.

Gil KM, Pugh SL, Klopp AH, Yeung AR, Wenzel L, Westin SN, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Deshmukh S, Kachnic LA, Bruner DW.

Gynecol Oncol. 2019 Jul;154(1):183-188. doi: 10.1016/j.ygyno.2019.04.682. Epub 2019 May 16.

PMID:
31104905
14.

Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.

Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH.

Radiother Oncol. 2019 Jun;135:58-64. doi: 10.1016/j.radonc.2019.02.012. Epub 2019 Mar 11.

PMID:
31015171
15.

Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.

Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG.

Brachytherapy. 2019 Jul - Aug;18(4):445-452. doi: 10.1016/j.brachy.2019.03.003. Epub 2019 Apr 13.

PMID:
30992185
16.

Compendium of fractionation choices for gynecologic HDR brachytherapy-An American Brachytherapy Society Task Group Report.

Albuquerque K, Hrycushko BA, Harkenrider MM, Mayadev J, Klopp A, Beriwal S, Petereit DG, Scanderbeg DJ, Yashar C.

Brachytherapy. 2019 Jul - Aug;18(4):429-436. doi: 10.1016/j.brachy.2019.02.008. Epub 2019 Apr 9. Review.

PMID:
30979631
17.

Deformable image registration for dose mapping between external beam radiotherapy and brachytherapy images of cervical cancer.

Rigaud B, Klopp A, Vedam S, Venkatesan A, Taku N, Simon A, Haigron P, de Crevoisier R, Brock KK, Cazoulat G.

Phys Med Biol. 2019 May 31;64(11):115023. doi: 10.1088/1361-6560/ab1378.

PMID:
30913542
18.

National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer.

Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA.

Gynecol Oncol. 2019 Mar;152(3):439-444. doi: 10.1016/j.ygyno.2018.11.005.

PMID:
30876486
19.

AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA; CGC, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 Feb;17(2):171-189. doi: 10.6004/jnccn.2019.0008.

PMID:
30787130
20.

Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).

Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C.

Brachytherapy. 2019 Mar - Apr;18(2):123-132. doi: 10.1016/j.brachy.2018.11.009. Epub 2019 Jan 18. Review.

PMID:
30665713
21.

Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).

Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C.

Gynecol Oncol. 2019 Mar;152(3):540-547. doi: 10.1016/j.ygyno.2018.10.016. Epub 2019 Jan 18. Review.

PMID:
30665615
22.

Prognostic factors impacting survival in early stage uterine carcinosarcoma.

Kurnit KC, Previs RA, Soliman PT, Westin SN, Klopp AH, Fellman BM, Lu KH, Ramondetta LM, Fleming ND.

Gynecol Oncol. 2019 Jan;152(1):31-37. doi: 10.1016/j.ygyno.2018.10.034. Epub 2018 Nov 8.

PMID:
30414738
23.

In reply to Keenan et al. Anatomic principles as the basis of target volume definition.

Eifel PJ, Klopp AH.

Radiother Oncol. 2019 Jul;136:198-199. doi: 10.1016/j.radonc.2018.06.024. Epub 2018 Sep 29. No abstract available.

PMID:
30279048
24.

Infant Feeding and Weight Gain: Separating Breast Milk From Breastfeeding and Formula From Food.

Azad MB, Vehling L, Chan D, Klopp A, Nickel NC, McGavock JM, Becker AB, Mandhane PJ, Turvey SE, Moraes TJ, Taylor MS, Lefebvre DL, Sears MR, Subbarao P; CHILD Study Investigators.

Pediatrics. 2018 Oct;142(4). pii: e20181092. doi: 10.1542/peds.2018-1092.

25.

Defining the Place of Adjuvant Chemotherapy and Radiation for High-Risk Endometrial Cancer From Recent Randomized Clinical Trials: Some Answers, More Questions.

Albuquerque K, Chino J, Klopp A, Kamrava M, Beriwal S.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):473-477. doi: 10.1016/j.ijrobp.2018.05.034. No abstract available.

PMID:
30238893
26.

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Gupta N, Johung KL, Klopp A, LaCasce AS, Lin C, Makarova-Rusher OV, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Palella F, Ratner L, Rizza S, Rudek MA, Taylor J, Tomlinson B, Wang CJ, Dwyer MA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Aug;16(8):986-1017. doi: 10.6004/jnccn.2018.0066.

PMID:
30099375
27.

Kinetics of Intratumoral Immune Cell Activation During Chemoradiation for Cervical Cancer.

Dorta-Estremera S, Colbert LE, Nookala SS, Yanamandra AV, Yang G, Delgado A, Mikkelson M, Eifel P, Jhingran A, Lilie LL, Welsh J, Schmeler K, Sastry JK, Klopp A.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):593-600. doi: 10.1016/j.ijrobp.2018.06.404. Epub 2018 Jul 12.

28.

Independent validation of machine performance check for the Halcyon and TrueBeam linacs for daily quality assurance.

Li Y, Netherton T, Nitsch PL, Gao S, Klopp AH, Balter PA, Court LE.

J Appl Clin Med Phys. 2018 Sep;19(5):375-382. doi: 10.1002/acm2.12391. Epub 2018 Jul 17.

29.

Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment.

Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1046-1056. doi: 10.1016/j.ijrobp.2018.03.028. Epub 2018 Mar 30. Review.

PMID:
30012524
30.

Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW.

J Clin Oncol. 2018 Aug 20;36(24):2538-2544. doi: 10.1200/JCO.2017.77.4273. Epub 2018 Jul 10. Erratum in: J Clin Oncol. 2019 Mar 20;37(9):761.

31.

Interplay effect on a 6-MV flattening-filter-free linear accelerator with high dose rate and fast multi-leaf collimator motion treating breast and lung phantoms.

Netherton T, Li Y, Nitsch P, Shaitelman S, Balter P, Gao S, Klopp A, Muruganandham M, Court L.

Med Phys. 2018 Jun;45(6):2369-2376. doi: 10.1002/mp.12899. Epub 2018 Apr 24.

PMID:
29611210
32.

Empowered to Serve: Implementing Community Stroke Outreach Using Peer Educators to Improve Readiness to Act Among Local Community Members.

Omelchenko N, Saban KL, Andresen P, Klopp A, Lau J.

J Neurosci Nurs. 2018 Apr;50(2):111-115. doi: 10.1097/JNN.0000000000000344.

PMID:
29521736
33.

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT.

Li Y, Netherton T, Nitsch PL, Balter PA, Gao S, Klopp AH, Court LE.

J Appl Clin Med Phys. 2018 May;19(3):52-57. doi: 10.1002/acm2.12276. Epub 2018 Mar 3.

34.

Radiation Is the Place to Start.

Klopp A.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):289. doi: 10.1016/j.ijrobp.2017.10.026. No abstract available.

PMID:
29353645
35.

Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy.

Stecklein SR, Frumovitz M, Klopp AH, Gunther JR, Eifel PJ.

Gynecol Oncol. 2018 Mar;148(3):474-479. doi: 10.1016/j.ygyno.2018.01.007. Epub 2018 Jan 12.

PMID:
29336837
36.

Perirenal Adiposity is Associated With Lower Progression-Free Survival From Ovarian Cancer.

Zhang Y, Coletta AM, Allen PK, Parikh AM, Cox-Mattin M, Meyer LA, Sun CC, Basen-Engquist KM, Lu KH, Klopp AH.

Int J Gynecol Cancer. 2018 Feb;28(2):285-292. doi: 10.1097/IGC.0000000000001165.

37.

Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward.

Glaser S, Mahantshetty U, Lee L, Klopp A, Beriwal S.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):505-509. doi: 10.1016/j.ijrobp.2017.06.2444. No abstract available.

PMID:
29280437
38.

Modes of Infant Feeding and the Risk of Childhood Asthma: A Prospective Birth Cohort Study.

Klopp A, Vehling L, Becker AB, Subbarao P, Mandhane PJ, Turvey SE, Lefebvre DL, Sears MR; CHILD Study Investigators, Azad MB.

J Pediatr. 2017 Nov;190:192-199.e2. doi: 10.1016/j.jpeds.2017.07.012.

PMID:
29144244
39.

Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.

Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH.

Gynecol Oncol. 2018 Jan;148(1):132-138. doi: 10.1016/j.ygyno.2017.10.017. Epub 2017 Oct 28.

PMID:
29089122
40.

Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma.

Gunther JR, Christensen EN, Allen PK, Ramondetta LM, Jhingran A, Fleming ND, Euscher ED, Lu KH, Eifel PJ, Klopp AH.

Int J Gynecol Cancer. 2018 Jan;28(1):114-121. doi: 10.1097/IGC.0000000000001135.

PMID:
28930812
41.

American Brachytherapy Society recurrent carcinoma of the endometrium task force patterns of care and review of the literature.

Kamrava M, Beriwal S, Erickson B, Gaffney D, Jhingran A, Klopp A, Park SJ, Viswanathan A, Yashar C, Lin L.

Brachytherapy. 2017 Nov - Dec;16(6):1129-1143. doi: 10.1016/j.brachy.2017.07.012. Epub 2017 Sep 6.

PMID:
28888417
42.

Development and validation of a rapid and robust method to determine visceral adipose tissue volume using computed tomography images.

Parikh AM, Coletta AM, Yu ZH, Rauch GM, Cheung JP, Court LE, Klopp AH.

PLoS One. 2017 Aug 31;12(8):e0183515. doi: 10.1371/journal.pone.0183515. eCollection 2017.

43.

Defining Prognostic Biomarkers and Optimal Adjuvant Treatment for Gynecologic Cancer.

Beriwal S, Klopp A, Mell L.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):1-4. doi: 10.1016/j.ijrobp.2017.01.014. No abstract available.

PMID:
28586944
44.

Factors prognostic of survival in advanced-stage uterine serous carcinoma.

Holman LL, Pal N, Iglesias DA, Soliman PT, Balakrishnan N, Klopp A, Broaddus RR, Fleming ND, Munsell MF, Lu KH, Westin SN.

Gynecol Oncol. 2017 Jul;146(1):27-33. doi: 10.1016/j.ygyno.2017.04.018. Epub 2017 Apr 30.

45.

In Reply to Mazeron etĀ al.

Swanick CW, Eifel PJ, Klopp AH.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):639. doi: 10.1016/j.ijrobp.2016.11.018. No abstract available.

PMID:
28126311
46.

Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.

Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):546-553. doi: 10.1016/j.ijrobp.2016.11.015. Epub 2016 Nov 17.

47.

Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy forĀ Cervical Cancer.

Swanick CW, Castle KO, Vedam S, Munsell MF, Turner LM, Rauch GM, Jhingran A, Eifel PJ, Klopp AH.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):793-800. doi: 10.1016/j.ijrobp.2016.07.035. Epub 2016 Jul 30.

48.

Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy.

Osborne EM, Klopp AH, Jhingran A, Meyer LA, Eifel PJ.

Pract Radiat Oncol. 2017 May - Jun;7(3):e165-e173. doi: 10.1016/j.prro.2016.09.003. Epub 2016 Sep 7.

PMID:
27743802
49.

A Quality Improvement Project: Using the STOP-BANG Tool in a Military Population to Improve Equity in Preoperative Screening.

Dixon SE, Haas SA, Klopp A, Carlson J.

J Perianesth Nurs. 2016 Oct;31(5):371-80. doi: 10.1016/j.jopan.2014.12.002. Epub 2016 Apr 6.

PMID:
27667343
50.

Patterns of recurrence and survival in neuroendocrine cervical cancer.

Stecklein SR, Jhingran A, Burzawa J, Ramalingam P, Klopp AH, Eifel PJ, Frumovitz M.

Gynecol Oncol. 2016 Dec;143(3):552-557. doi: 10.1016/j.ygyno.2016.09.011. Epub 2016 Sep 16.

Supplemental Content

Support Center